Shared Research logo
  • Home
  • All Companies
    All Companies
    Companies
    Recently viewed
    Browse companies...
  • English
    日本語
  • Log in
  • Sign up
Overview
My Comments
My Notes
Carna Biosciences

Carna Biosciences 4572

カルナバイオサイエンス
Carna Biosciences, Inc.
Recent Updates
2023-09-21
Liquidation and dissolution plan of a licensee, FRTX
2023-09-21
1H FY12/23 report update
2023-08-26
1H FY12/23 Flash Update
Get in touch
Address:BMA 3F 1-5-5 Minatojima-Minamimachi,Chuo-ku, Kobe 650–0047
Website:https://www.carnabio.com/english/ir/news/2019.html
Summary
Carna Biosciences (Carna) researches and develops small molecule drug candidates to address unmet medical needs across several therapeutic areas including oncology, inflammatory diseases (rheumatoid arthritis), and neurodegenerative diseases (Alzheimer’s disease). The aim is to out-license its pipeline of drug candidates, including potential blockbuster drugs, to produce revenues by letting partners use its IP to commercialize certain drugs.
Key dates
2023-11-07
Next earnings announcement
2015-10-02
Coverage initiation